– USA, NY – Renalytix plc (LON: RENX / OTC: RNLXY), an artificial intelligence-enabled in vitro diagnostics company, announced the appointment of Robert Naylor to its Board as Non-Executive Director with immediate effect.
“It is a pleasure to have Robert join the Board of Renalytix, bringing with him a wealth of knowledge in the life sciences sector. Robert’s capital markets experience and insight is invaluable to us as an AIM listed business,” said CEO, James McCullough.
About Robert Naylor
Robert Naylor has 29 years of experience in capital markets, specializing in both the life sciences and investment companies sectors. He is CEO and Co-Founder of Intuitive Investments Group plc, a London Stock Exchange Specialist Funds Segment investment company providing investors with exposure to fast-growing technology and life sciences businesses. Robert Naylor is also a Non-Executive Director of NIOX Group PLC.
Robert Naylor was Chairman of Hipgnosis Songs Fund Limited, an FTSE 250 company, and Chairman of Round Hill Music Royalty FundLimitede. Earlier in his career, he held various positions within JP Morgan Asset Management Limited, Panmure Gordon (UK) Limit, ed and Cenkos Securities plc. Robert is a qualified chartered accountant, starting his career with Ernst & Young in 1996.
About Renalytix
Renalytix is an in-vitro diagnostics and laboratory services company that is the global founder and leader in the new field of prognoses for kidney health. The leadership team, with a combined 200+ years of healthcare and in-vitro diagnostic experience, has designed its KidneyIntelX laboratory-developed test to enable risk assessment for rapid progressive decline in kidney function in adult patients with T2D and early CKD (stages 1-3). We believe that by understanding how disease will progress, patients and providers can take action early to improve outcomes and reduce overall health system costs.
For more: https://renalytix.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.